These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 187698)
1. Reversal of SV40 tumor-mediated suppression of spleen cell cytotoxicity by antibody. Prather SO; Lausch RN J Immunol; 1977 Jan; 118(1):203-10. PubMed ID: 187698 [TBL] [Abstract][Full Text] [Related]
2. Analysis of sera from SV40-immunized and tumor-bearing hosts for blocking activity and antibody-dependent cellular cytotoxicity. Lausch RN; Sofranko J; Prather SO J Immunol; 1975 Sep; 115(3):682-7. PubMed ID: 168264 [TBL] [Abstract][Full Text] [Related]
3. Spleen cell-mediated cytotoxicity of hamster cells transformed by Herpes simplex virus: evidence for virus-specific membrane antigen. Lausch RN; Jones C; Christie D; Hay KA; Rapp F J Immunol; 1975 Jan; 114(1 Pt 2):459-65. PubMed ID: 163859 [TBL] [Abstract][Full Text] [Related]
4. Inability of antiserum active in antibody-dependent cellular cytotoxicity and arming tests to protect against simian virus 40 tumor cell challenge. Prather SO; Geller RW; Lausch RN J Natl Cancer Inst; 1979 May; 62(5):1273-7. PubMed ID: 220449 [TBL] [Abstract][Full Text] [Related]
5. Membrane-associated antigen from the SV40-induced hamster fibrosarcoma, para-7. I. Role in immune complex formation and effector cell blockade. Prather SO; Lausch RN Int J Cancer; 1976 Dec; 18(6):820-8. PubMed ID: 62726 [TBL] [Abstract][Full Text] [Related]
7. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity. Bright RK; Shearer MH; Kennedy RC J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411 [TBL] [Abstract][Full Text] [Related]
8. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2. Yoshizawa H; Chang AE; Shu S J Immunol; 1991 Jul; 147(2):729-37. PubMed ID: 1830072 [TBL] [Abstract][Full Text] [Related]
9. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells. Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777 [TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera. Peters CJ; Theofilopoulos AN J Immunol; 1977 Sep; 119(3):1089-96. PubMed ID: 70469 [TBL] [Abstract][Full Text] [Related]
11. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis. Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716 [TBL] [Abstract][Full Text] [Related]
12. Separation of effector cells mediating antibody-dependent cellular cytotoxicity (ADC) to erythrocyte targets from those mediating ADC to tumor targets. Pollack SB; Nelson K; Grausz JD J Immunol; 1976 Apr; 116(4):944-6. PubMed ID: 815438 [TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. Shore SL; Black CM; Melewicz FM; Wood PA; Nahmias AJ J Immunol; 1976 Jan; 116(1):194-201. PubMed ID: 173757 [TBL] [Abstract][Full Text] [Related]
14. Immunological activity of regional lymph nodes in tumor-bearing mice. Barna BP; Deodhar SD Cancer Res; 1979 Jul; 39(7 Pt 1):2711-7. PubMed ID: 312691 [TBL] [Abstract][Full Text] [Related]
15. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro. Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918 [TBL] [Abstract][Full Text] [Related]
16. In vivo blocking of SV40 virus-induced antitumor resistance by Syrian hamster sera from early stages of primary SV40 carcinogenesis. Volpe EA Neoplasma; 1976; 23(4):345-53. PubMed ID: 187966 [TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity. Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay. Greenberg AH; Shen L; Medley G Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417 [TBL] [Abstract][Full Text] [Related]
20. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells. Blasecki JW; Tevethia SS J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]